Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects

  1. Mirzaei, S.
  2. Gholami, M.H.
  3. Hashemi, F.
  4. Zabolian, A.
  5. Farahani, M.V.
  6. Hushmandi, K.
  7. Zarrabi, A.
  8. Goldman, A.
  9. Ashrafizadeh, M.
  10. Orive, G.
Revue:
Drug Discovery Today

ISSN: 1878-5832,  1359-6446

Année de publication: 2022

Volumen: 27

Número: 2

Pages: 436-455

Type: Révision

DOI: 10.1016/J.DRUDIS.2021.09.020 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus